These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33017224)

  • 1. Exploring metal availability in the natural niche of
    van Beek LF; Surmann K; van den Berg van Saparoea HB; Houben D; Jong WSP; Hentschker C; Ederveen THA; Mitsi E; Ferreira DM; van Opzeeland F; van der Gaast-de Jongh CE; Joosten I; Völker U; Schmidt F; Luirink J; Diavatopoulos DA; de Jonge MI
    Virulence; 2020 Dec; 11(1):1310-1328. PubMed ID: 33017224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model.
    Bogaert D; Weinberger D; Thompson C; Lipsitch M; Malley R
    Infect Immun; 2009 Apr; 77(4):1613-22. PubMed ID: 19168741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.
    Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X
    Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children.
    Ditse Z; Adrian PV; Kuwanda L; Madhi SA
    Vaccine; 2013 Sep; 31(40):4421-7. PubMed ID: 23845819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.
    Khan MN; Xu Q; Pichichero ME
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
    Tostes RO; Rodrigues TC; da Silva JB; Schanoski AS; Oliveira ML; Miyaji EN
    PLoS One; 2017; 12(1):e0170157. PubMed ID: 28103277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with pneumococcal elongation factor Tu enhances serotype-independent protection against Streptococcus pneumoniae infection.
    Nagai K; Domon H; Maekawa T; Hiyoshi T; Tamura H; Yonezawa D; Habuka R; Saitoh A; Terao Y
    Vaccine; 2019 Jan; 37(1):160-168. PubMed ID: 30442480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against fatal pneumonia through mucosal and subcutaneous immunization with the pneumococcal SP0148 protein.
    Huang J; Luo S; Huang M; Zhang T; Min Z; Liu C; Zhang Q; Yang J; Min X
    Microb Pathog; 2019 Apr; 129():206-212. PubMed ID: 30772476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies.
    Brookes RH; Ming M; Williams K; Hopfer R; Gurunathan S; Gallichan S; Tang M; Ochs MM
    Hum Vaccin Immunother; 2015; 11(7):1836-9. PubMed ID: 25912273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.
    Zhang Y; Masi AW; Barniak V; Mountzouros K; Hostetter MK; Green BA
    Infect Immun; 2001 Jun; 69(6):3827-36. PubMed ID: 11349048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of Streptococcus pneumoniae in children living in southwest China and assessment of a potential protein vaccine, rPfbA.
    Yan Z; Cui Y; Zhou W; Li W; Tan X; Chen W; Zhang J; Jiang Y
    Vaccine; 2019 Jan; 37(5):721-731. PubMed ID: 30611601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice.
    Converso TR; Goulart C; Rodriguez D; Darrieux M; Leite LC
    Vaccine; 2017 Jan; 35(1):149-155. PubMed ID: 27884476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
    Wu K; Yao R; Wang H; Pang D; Liu Y; Xu H; Zhang S; Zhang X; Yin Y
    Vaccine; 2014 Jul; 32(33):4179-88. PubMed ID: 24945468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal pep27 mutant immunization stimulates cytokine secretion and confers long-term immunity with a wide range of protection, including against non-typeable strains.
    Kim GL; Choi SY; Seon SH; Lee S; Park SS; Song JY; Briles DE; Rhee DK
    Vaccine; 2016 Dec; 34(51):6481-6492. PubMed ID: 27865564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides.
    Denoël P; Godfroid F; Hermand P; Verlant V; Poolman J
    Vaccine; 2011 Sep; 29(38):6451-3. PubMed ID: 21315695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
    Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
    Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
    Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Naturally Acquired Immunity to
    Ramos-Sevillano E; Ercoli G; Brown JS
    Front Immunol; 2019; 10():358. PubMed ID: 30881363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.